President & CEO of Amag Pharmaceuticals Inc (AMAG, Financial) William K Heiden bought 10,000 shares of AMAG on 05/09/2019 at an average price of $10.7 a share. The total cost of this purchase was $107,000.
AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer. AMAG Pharmaceuticals Inc has a market cap of $377.610 million; its shares were traded at around $11.19 with and P/S ratio of 0.89.
CEO Recent Trades:
- President & CEO William K Heiden bought 10,000 shares of AMAG stock on 05/09/2019 at the average price of $10.7. The price of the stock has increased by 4.58% since.
Directors and Officers Recent Trades:
- Chief Human Resources Officer Elizabeth Scott Bolgiano bought 5,000 shares of AMAG stock on 05/09/2019 at the average price of $10.93. The price of the stock has increased by 2.38% since.
For the complete insider trading history of AMAG, click here
.
